Non-profit trade association BioNorth Texas recently held the first meeting of its Board of Directors, bringing together a group of North Texas biotech professionals at The Foundry in Dallas. During the inaugural meeting, board members discussed the early accomplishments of the organization, laid out plans for future events and nominated board members to newly established committees which seek to represent and grow the life sciences industry in the North Texas region, focusing on establishing partnerships with local and state organizations, researchers, and biotech companies.
BioNorth Texas’ Board of Directors (BOD) works in collaboration with the association’s Executive Committee (EC) to fulfill the existing gap among the biotechnology and life sciences’ industries in North Texas, enhancing the convergence between research and supporting industries. The BOD and EC plan to establish a network comprised of key partners and Texas-based biotech organizations to facilitate the translation of groundbreaking life sciences research into commercial success for the region.
The partnerships established by BioNorth Texas include one with the Texas Healthcare & Bioscience Institute (THBI) and with UT System’s FreshAIR initiative. To make these collaborations possible, the association designed a plan of upcoming events and initiatives, which include its Board of Directors meetings, investment workshops, regulatory events and talent committee meetings.
BioNorth Texas also supports other events organized by its partners Health Wildcatters, TECH Fort Worth, BioHouston, Texas FreshAIR, and Life Science Nation’s RESI Conference, with the next “BioNorthTX is Open for Business” Industry Update and Networking Event to take place on June 10th.
The president and CEO of BioNorth Texas, JJ Spegele led the first meeting of the association’s Board of Directors, along with BioNews Services, Inc., president Chris Comish and Life Science Practice Leader, Risk Consulting Partners vice-president, Kay Kirk Tieman. Comish and Tieman are co-founders of BioNorth Texas.
Melissa Krauth, Principal, Life Science Investments, 2M Companies; Jorge Varela, Assistant Director, Tech Fort Worth; David Foster, Ph.D., J.D., Partner, Roberts Foster LLP, Co-founder & CEO, Tuevol Therapeutics, Co-founder and Interim CEO, FPRT Bio, and Co-founder, BioNorthTX are also active directors of the Board.
Other board directors in attendance included Frank Grassler, J.D., VP of Technology Development at UTSW, Vipin Garg, Ph.D., CEO of Neos Therapeutics; Debbie Hutchinson, President of Wound Management Technologies, Inc.; Art Clapp, CEO of BioDeal Ventures/Science Cosmetique, Inc.; Mike Pine, Owner of Williams and Company CPAs, PLLC; Jaime Walkowiak, J.D., VP Research Operations & Business Development at Baylor Research Institute, Paul Herchman, CEO of ThermiHealth and Robin Frink, Ph.D., a Postdoctoral Fellow at UT Southwestern Medical Center and the Marketing and Research Associate at BioNorthTX.
BioNorth Texas, which was established in February of last year, held its inaugural executive roundtable event on November 20. At the organization’s first meeting, BioNorth Texas co-founders Chris Comish, Kay Tieman, and David Foster of Roberts Foster, LLP established the group’s efforts to address the perceived “regional gap,” connecting resources for productivity, serving the North Texas life sciences community, and furthering its development as a life sciences hub.